1. Home
  2. NFG vs TGTX Comparison

NFG vs TGTX Comparison

Compare NFG & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Fuel Gas Company

NFG

National Fuel Gas Company

HOLD

Current Price

$78.90

Market Cap

7.8B

Sector

Utilities

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$52.35

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFG
TGTX
Founded
1902
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.5B
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
NFG
TGTX
Price
$78.90
$52.35
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$102.00
$49.80
AVG Volume (30 Days)
656.0K
2.8M
Earning Date
04-29-2026
05-04-2026
Dividend Yield
2.43%
N/A
EPS Growth
576.19
1746.67
EPS
4.58
0.12
Revenue
$2,277,541,000.00
$2,785,000.00
Revenue This Year
$15.04
$49.08
Revenue Next Year
$23.44
$26.69
P/E Ratio
$16.93
$446.04
Revenue Growth
17.11
N/A
52 Week Low
$75.17
$25.37
52 Week High
$97.06
$57.38

Technical Indicators

Market Signals
Indicator
NFG
TGTX
Relative Strength Index (RSI) 53.56 65.27
Support Level $77.51 $28.57
Resistance Level $78.90 $57.38
Average True Range (ATR) 1.27 2.37
MACD 0.49 -0.12
Stochastic Oscillator 95.99 50.17

Price Performance

Historical Comparison
NFG
TGTX

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company involved in natural gas production, gathering, transportation, distribution, and marketing. It operates through three segments: Integrated Upstream and Gathering, Pipeline and Storage, and Utility. The majority of revenue comes from the Integrated Upstream and Gathering segment, which focuses on Seneca's natural gas exploration and development in the Appalachian region and Midstream operations supporting gas processing and gathering. The Pipeline and Storage segment transports and stores natural gas for customers in the northeastern United States and Canada, while the Utility segment supplies natural gas to retail customers in western New York and northwestern Pennsylvania. the company opeartes in United States.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Share on Social Networks: